The clinical effectiveness of Fidaxomicin compared to Vancomycin in the treatment of Clostridioides difficile infection, a single center real-world experience.
Majd S AlsoubaniJennifer K ChowAngie Mae RoddayLaura A McDermottSeth T WalkDavid M KentDavid R SnydmanPublished in: The Journal of infectious diseases (2024)
In the treatment of CDI, we showed that real-world use of fidaxomicin is associated with lower risk of a composite endpoint of treatment failure.